AI assistant
SURMODICS INC — Director's Dealing 2017
Sep 13, 2017
32845_dirs_2017-09-13_59a6cdf6-5078-4401-80f3-442a97bb7f07.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2017-09-11
Reporting Person: Stich Joseph J. (VP and GM, IVD)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-11 | Common Stock | S | 1000 | $27.2835 | Disposed | 39989 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2017.
F2: Reflects the weighted average price of 1,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on September 11, 2017 with sale prices ranging from $27.20 to $27.55 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Includes 317 shares acquired through the Employee Stock Purchase Plan for the phase ending 8/31/17.